about
Synthesis, Superoxide Dismutase Mimetic and Anticancer Activities of Metal Complexes of 2,2-Dimethylpentanedioic Acid(2dmepdaH(2)) and 3,3-Dimethylpentanedioic acid(3dmepdaH(2)): X-Ray Crystal Structures of [Cu(3dmepda)(bipy)](2). 6H(2)O and [Cu(2dmSynthesis and Anti-Candida Activity of Cobalt(II) Complexes of Benzene-1,2-Dioxyacetic Acid (bdoaH(2)). X-Ray Crystal Structures of [Co(bdoa)(H(2)O)(3)] 3.5H(2)O and {[CO(phen)(3)](bdoa)}(2)24H(2)O (phen = 1,10-Phenanthroline).Insights into the mode of action of the anti-Candida activity of 1,10-phenanthroline and its metal chelates.1,10-Phenanthroline-5,6-Dione-Based Compounds Are Effective in Disturbing Crucial Physiological Events of Phialophora verrucosa.Deciphering the antimicrobial activity of phenanthroline chelators.Tuberculosis: An Inorganic Medicinal Chemistry Perspective.Spectroscopic studies, DFT calculations, and cytotoxic activity of novel silver(I) complexes of hydroxy ortho-substituted-nitro-2H-chromen-2-one ligands and a phenanthroline adduct.The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance.Radical-induced DNA damage by cytotoxic square-planar copper(II) complexes incorporating o-phthalate and 1,10-phenanthroline or 2,2'-dipyridyl.Copper(II) complexes of salicylic acid combining superoxide dismutase mimetic properties with DNA binding and cleaving capabilities display promising chemotherapeutic potential with fast acting in vitro cytotoxicity against cisplatin sensitive and rNovel silver(I) complexes of coumarin oxyacetate ligands and their phenanthroline adducts: Biological activity, structural and spectroscopic characterisation.Biological activity and coordination modes of copper(II) complexes of Schiff base-derived coumarin ligands.Role of cell cycle events and apoptosis in mediating the anti-cancer activity of a silver(I) complex of 4-hydroxy-3-nitro-coumarin-bis(phenanthroline) in human malignant cancer cells.Antifungal Potential of Copper(II), Manganese(II) and Silver(I) 1,10-Phenanthroline Chelates Against Multidrug-Resistant Fungal Species Forming the Candida haemulonii Complex: Impact on the Planktonic and Biofilm Lifestyles.In vitro anti-tumour effect of 1,10-phenanthroline-5,6-dione (phendione), [Cu(phendione)3](ClO4)2.4H2O and [Ag(phendione)2]ClO4 using human epithelial cell lines.In vitro anti-tumour and cyto-selective effects of coumarin-3-carboxylic acid and three of its hydroxylated derivatives, along with their silver-based complexes, using human epithelial carcinoma cell lines.In vitro cancer chemotherapeutic activity of 1,10-phenanthroline (phen), [Ag2(phen)3(mal)]x2H2O, [Cu(phen)2(mal)]x2H2O and [Mn(phen)2(mal)]x2H2O (malH2=malonic acid) using human cancer cells.Induction of apoptosis in yeast and mammalian cells by exposure to 1,10-phenanthroline metal complexes.Anti-Pseudomonas aeruginosa activity of 1,10-phenanthroline-based drugs against both planktonic- and biofilm-growing cells.Silver(I) complexes of 9-anthracenecarboxylic acid and imidazoles: synthesis, structure and antimicrobial activity.Hexakis(prop-2-enamide)copper(II) bis(perchlorate) and hexakis(prop-2-enamide)manganese(II) bis(perchlorate).Mode of anti-fungal activity of 1,10-phenanthroline and its Cu(II), Mn(II) and Ag(I) complexes.Copper(II) complexes of coumarin-derived Schiff bases and their anti-Candida activity.Targeting the folate receptor: improving efficacy in inorganic medicinal chemistry.Water-soluble and photo-stable silver(I) dicarboxylate complexes containing 1,10-phenanthroline ligands: Antimicrobial and anticancer chemotherapeutic potential, DNA interactions and antioxidant activity.A study of the role of apoptotic cell death and cell cycle events mediating the mechanism of action of 6-hydroxycoumarin-3-carboxylatosilver in human malignant hepatic cellsBis-phenanthroline copper(ii) phthalate complexes are potent in vitro antitumour agents with ‘self-activating’ metallo-nuclease and DNA binding propertiesTetrameric and polymeric silver complexes of the omeprazole scaffold; synthesis, structure, in vitro and in vivo antimicrobial activities and DNA interactionSynthesis, X-ray crystal structures and biomimetic and anticancer activities of novel copper(II)benzoate complexes incorporating 2-(4'-thiazolyl)benzimidazole (thiabendazole), 2-(2-pyridyl)benzimidazole and 1,10-phenanthroline as chelating nitrogenThe quantum topological electrostatic potential as a probe for functional group transferabilityDNA cleavage reactions of the dinuclear chemotherapeutic agent copper(II) bis-1,10- phenanthroline terephthalateMolecular structure and spectroscopic studies on novel complexes of coumarin-3-carboxylic acid with Ni(II), Co(II), Zn(II) and Mn(II) ions based on density functional theoryIn-vivo evaluation of the response of Galleria mellonella larvae to novel copper(II) phenanthroline-phenazine complexesUnprecedented in Vitro Antitubercular Activitiy of Manganese(II) Complexes Containing 1,10-Phenanthroline and Dicarboxylate Ligands: Increased Activity, Superior Selectivity, and Lower Toxicity in Comparison to Their Copper(II) AnalogsCu(ii) phenanthroline-phenazine complexes dysregulate mitochondrial function and stimulate apoptosisAnti-Trichomonas vaginalis activity of 1,10-phenanthroline-5,6-dione-based metallodrugs and synergistic effect with metronidazoleCopper(II) complexes of coumarin-derived Schiff base ligands: Pro- or antioxidant activity in MCF-7 cells?(E)-6,6'-(Diazene-1,2-di-yl)bis-(1,10-phenanthrolin-5-ol) tri-chloro-methane disolvate: a superconjugated ligandDisarming Pseudomonas aeruginosa Virulence by the Inhibitory Action of 1,10-Phenanthroline-5,6-Dione-Based Compounds: Elastase B (LasB) as a Chemotherapeutic TargetSynthesis and antimicrobial activity of a phenanthroline-isoniazid hybrid ligand and its Ag+ and Mn2+ complexes
P50
Q35605978-D983B352-C39E-4D2A-8BE7-CB4DF673123DQ36626626-429880B2-1898-4792-BCEA-999D2ACFD55FQ36626738-3746DCE1-01FD-411D-9C4B-E1CBB53A0630Q37611695-0B38F162-0F1A-4C37-93B0-8BE6A8F7013FQ37997842-EAC7B9E7-2F50-414D-AF18-39698FCCFC4AQ38409959-3D3D079E-31CC-456D-B06D-A5EC79C46840Q38825887-771E3647-FB6F-45A1-A4C5-34756BD7E1A8Q38970838-9AE5988D-4DDE-4E37-9713-F5DF7AC7F3C2Q39338230-3EDF9389-5C9E-4552-8402-57C2AA8A40A1Q39400284-A83F54E0-7FA8-44EA-8613-102138A03454Q39492072-45093E43-80B3-48CC-A65A-80E61F39522DQ39643776-EE653DC4-C907-41DE-A359-2994D26C61F2Q39910895-C4499A6E-F2F6-49C4-ACD9-8ED9CFB314BFQ40119738-B2F57A22-9D09-4393-AEAB-9AB4469AE9FFQ40222223-F0508735-BF54-4D72-9D1A-3009B384B09CQ40228417-9D035EE2-E044-4EA1-9261-6C0E7B5361E2Q40272940-1ECEAA46-6EF5-4DC7-8D73-4B3CDBFE9E2EQ40614959-D5463A1A-54D2-4BB1-AC61-E1CFF8402CC6Q40976300-2FCDAC0F-6DA1-4ADE-B70D-AD320D492A1FQ42013658-D91B8BFF-9FD7-4889-8633-CD15FF479C0FQ42836240-198D7736-F9A2-439C-9E0F-FF42F813328FQ44305663-1B7E15DF-5E33-466C-B179-FF9BBD80AE05Q45920384-4DA51AB0-2945-4F3D-9B7C-825CB4AEF962Q50102558-8821316C-2A52-413E-A592-6641CF9B8B05Q52984294-D94422C6-9ECE-4D7A-A59C-E661F427D1C8Q56744022-28C38978-ACBF-4FF2-9123-7B30AAFEF970Q60649250-FC04F1B8-7F0B-4B8A-9D8F-FF56074D5E52Q63344574-BF061CBB-5408-4696-951F-6F42D6B5244BQ80070187-E905C404-06D2-4AD4-BFF1-1CD41C7C32A9Q80847417-DC29C3B9-A395-4C07-A642-0A1EC222945BQ83112000-657F6329-1F42-45E1-AA60-C6D93C98A00CQ85090407-FB47D7C7-F379-4511-B821-58BBE4DDED9AQ89116439-63B90323-33BF-47EF-813A-C3918EEB0209Q90258915-89D711B0-DC3A-4A71-9A5F-9EDC364C953FQ91263735-723B4B86-6067-46B0-947E-263C0C2CEFCCQ91399168-B9ED26AE-6E5E-4A9D-B11F-1A54FB1B7E32Q92137331-8004F9C6-690E-4168-80B1-A3AAAA7127C7Q92652337-27DA6F06-290C-4005-AC99-2BF7AED4A3F9Q92712303-62EA58FC-AD53-4294-A31A-DC2FA97353D2Q92963542-CE77A5D9-6904-4B7B-8ED5-BBD42FE2536C
P50
description
Forscher
@de
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究員
@ja
研究者
@zh
name
Michael Devereux
@en
Michael Devereux
@nl
type
label
Michael Devereux
@en
Michael Devereux
@nl
prefLabel
Michael Devereux
@en
Michael Devereux
@nl
P106
P31
P496
0000-0002-5378-0536